Pharmacokinetics, Safety and Tolerability of Rotigotine Transdermal Patch in Healthy Japanese and Caucasian Subjects

被引：0
|
作者：
Willi Cawello
Seong R. Kim
Marina Braun
Jan-Peer Elshoff
Junji Ikeda
Tomoo Funaki
机构：
[1] UCB Pharma,
[2] Otsuka Pharmaceutical Co. Ltd.,undefined
来源：
Clinical Drug Investigation | 2014年 / 34卷
关键词：
Japanese Subject; Rotigotine; Caucasian Subject; Dopamine Receptor Agonist; Patch Application;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：95 / 105
页数：10
相关论文
共 50 条
  • [21] Pharmacokinetics of repaglinide in healthy Caucasian and Japanese subjects
    Thomsen, MS
    Chassard, D
    Evène, E
    Nielsen, KK
    Jorgensen, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (01): : 23 - 28
  • [22] A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects
    Harada-Shiba, Mariko
    Ali, Shazia
    Gipe, Daniel A.
    Gasparino, Evelyn
    Son, Vladimir
    Zhang, Yi
    Pordy, Robert
    Catapano, Alberico L.
    ATHEROSCLEROSIS, 2020, 314 : 33 - 40
  • [23] Multiple-Dose Pharmacokinetics, Safety, and Tolerability of Aprocitentan, a Dual Endothelin Receptor Antagonist, in Healthy Japanese and Caucasian Subjects
    Fontes, Magda S. C.
    Dingemanse, Jasper
    Sidharta, Patricia N.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (07): : 718 - 725
  • [24] Clinical pharmacokinetics, pharmacodynamics, safety and tolerability of darexaban, an oral direct factor Xa inhibitor, in healthy Caucasian and Japanese subjects
    Kadokura, Takeshi
    Kashiwa, Makoto
    Groenendaal, Dorien
    Heeringa, Marten
    Mol, Roelof
    Verheggen, Frank
    Garcia-Hernandez, Alberto
    Onkels, Hartmut
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2013, 34 (08) : 431 - 441
  • [25] Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects
    Liu, Yun
    Tomlinson, Brian
    Guo, Jiyuan
    Asghamejad, Mahnaz
    Bauer, Lars
    Surmann, Erwin
    Guo, Xiaojuan
    Elshoff, Jan-Peer
    CLINICAL THERAPEUTICS, 2018, 40 (07) : 1108 - 1121
  • [26] Pharmacokinetics and safety of single and multiple doses of rasagiline in healthy Japanese and caucasian subjects
    Elgart, Anna
    Rabinovich-Guilatt, Laura
    Eyal, Eli
    Gross, Aviva
    Spiegelstein, Ofer
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 124 (03) : 273 - 284
  • [27] Pharmacokinetics, Pharmacodynamics, and Safety of Rasagiline Transdermal Patch: A Preliminary Study in Healthy Chinese Subjects
    Wenjia Zhou
    Chengzhe Lv
    Quanying Zhang
    Shunlin Zong
    Meng Wang
    Clinical Drug Investigation, 2018, 38 : 125 - 133
  • [28] Pharmacokinetics, safety, and tolerability of ceftolozane/tazobactam in healthy Japanese, Chinese, and white subjects
    Aiudi, Anthony
    Miller, Benjamin
    Krishna, Gopal
    Adedoyin, Adedayo
    Xiao, Alan
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 (06) : 625 - 633
  • [29] Pharmacokinetics, safety and tolerability of mipomersen in healthy Japanese volunteers and comparison with Western subjects
    Li, Zhaoyang
    Hard, Marjie L.
    Andersen, Grit
    Pabst, Guenther
    Wagener, Gilbert
    Singh, Tejdip
    Chin, Wai
    Culm-Merdek, Kerry
    Boltje, Ingrid
    von Moltke, Lisa L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (04) : 314 - 320
  • [30] Pharmacokinetics, Pharmacodynamics, and Safety of Rasagiline Transdermal Patch: A Preliminary Study in Healthy Chinese Subjects
    Zhou, Wenjia
    Lv, Chengzhe
    Zhang, Quanying
    Zong, Shunlin
    Wang, Meng
    CLINICAL DRUG INVESTIGATION, 2018, 38 (02) : 125 - 133
12345